Sign inGet started

Mano Michael

Insider CIK 1837741 · KPTI SVP, General Counsel&Secretary

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KPTI Karyopharm Therapeutics In S Sale2026-05-142026-05-15266$9.50 $2.5K94,398SEC↗
KPTI Karyopharm Therapeutics In A Award2026-05-132026-05-15700— $094,664SEC↗
KPTI Karyopharm Therapeutics In S Sale2026-03-022026-03-033,526$9.41 $33.2K93,964SEC↗
KPTI Karyopharm Therapeutics In A Award2026-01-312026-02-0332,415— $097,490SEC↗
KPTI Karyopharm Therapeutics In A Award2025-10-152025-10-1643,650— $065,075SEC↗
KPTI Karyopharm Therapeutics In S Sale2025-09-152025-09-16234$6.43 $1.5K21,425SEC↗
KPTI Karyopharm Therapeutics In A Award2025-09-122025-09-16612— $021,659SEC↗
KPTI Karyopharm Therapeutics In S Sale2025-03-042025-03-062,793$6.29 $17.6K21,047SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2025-02-282025-03-044,500— $04,500SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2025-02-282025-03-046,666— $06,666SEC↗
KPTI Karyopharm Therapeutics In A Award2025-02-282025-03-043,333— $021,590SEC↗
KPTI Karyopharm Therapeutics In A Award2025-02-282025-03-042,250— $023,840SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-09-042024-09-053,971$0.72 $2.9K273,881SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-03-012024-03-043,576$1.20 $4.3K277,852SEC↗
KPTI Karyopharm Therapeutics In S Sale2024-02-292024-03-0416,973$1.17 $19.9K281,428SEC↗
KPTI Karyopharm Therapeutics In A Award2024-02-282024-02-29147,000— $0298,401SEC↗
KPTI Karyopharm Therapeutics In A Award2024-01-242024-01-259,167— $0151,401SEC↗
KPTI Karyopharm Therapeutics In S Sale2023-09-012023-09-053,888$1.33 $5.2K142,234SEC↗
KPTI Karyopharm Therapeutics In S Sale2023-03-012023-03-026,878$3.03 $20.8K146,122SEC↗
KPTI Karyopharm Therapeutics In A Award2023-02-282023-03-0270,000— $0153,000SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2022-08-312022-09-0130,000— $030,000SEC↗
KPTI Karyopharm Therapeutics In A Award2022-08-312022-09-0120,000— $083,000SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2022-02-282022-03-0281,000— $081,000SEC↗
KPTI Karyopharm Therapeutics In A Award2022-02-282022-03-0263,000— $063,000SEC↗